The efficacy of mebendazole was tested in two well-characterized transgenic mouse models of pancreatic cancer, the KC, caerulein-induced model of PanIN progression and the KPC transgenic mouse model of advanced, metastatic PDAC. The gene discussed is CALCA; the disease is familial pancreatic carcinoma.